(Q37293994)

19 August 2017

1 reference

title

Genetic variants associated with cisplatin-induced ototoxicity (English)

1 reference

19 August 2017

1 reference

2

Sophie D Fosså

1 reference

19 August 2017

Jan Oldenburg

1

1 reference

19 August 2017

Tone Ikdahl

series ordinal

3

1 reference

19 August 2017

publication date

1 October 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

10

1 reference

19 August 2017

page(s)

1521-1530

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

19 August 2017

1 reference

The resurgence of platinum-based cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Cisplatin ototoxicity in children: a practical grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Platinum Compound-Related Ototoxicity in Children: Long-Term Follow-Up Reveals Continuous Worsening of Hearing Loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Screened and unscreened hearing threshold levels for the adult population: results from the Nord-Trøndelag Hearing Loss Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Otoacoustic emissions, their origin in cochlear function, and use.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Scale for chemotherapy-induced long-term neurotoxicity (SCIN): psychometrics, validation, and findings in a large sample of testicular cancer survivors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Cochlear structure and function after round window application of ototoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Relationship between cisplatin administration and the development of ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Inner ear histopathology in patients treated with cis-platinum.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Histopathology of human temporal bone after cis-platinum, radiation, or both.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Cisplatin Ototoxicity Involves Organ of Corti, Stria Vascularis and Spiral Ganglion: Modulation by αMSH and ORG 2766

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Future opportunities in preventing cisplatin induced ototoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Cisplatin-induced hearing loss: influence of the mode of drug administration in the guinea pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Curing metastatic cancer: lessons from testicular germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Regulation of JNK signaling by GSTp

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Differential effects of glutathione S-transferase pi (GSTP1) haplotypes on cell proliferation and apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Hearing genes and cisplatin deafness: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Identifying genetic variants that contribute to chemotherapy-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.10.1521

10.2217/14622416.9.10.1521

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference